| Primary information |
|---|
| sequence ID | Seq_9462 |
| Peptide sequence | VVSLGSPSGEVSHPRKT |
| CancerPDF_ID | CancerPDF_ID1682, CancerPDF_ID8095, CancerPDF_ID10285, |
| PMID | 21136997,24982608,21805675 |
| Protein Name | Alpha-2-HS-glycoprotein,Alpha-2-HS-glycoprotein,Alpha-2-HS-glycoprotein |
| UniprotKB Entry Name | FETUA_HUMAN,FETUA_HUMAN,FETUA_HUMAN |
| Fluid | Serum,Urine,Urine |
| M/Z | 1735.9217,NA,1736.9297 |
| Charge | 1,NA,NA |
| Mass (in Da) | NA,NA,NA |
| fdr | NA,NA,NA |
| Profiling Technique | LC-MS,Nano-LC-MS,MALDI-TOF |
| Peptide Identification technique | LC-MS-MS/MS,MS/MS,MALDI-TOF-MS |
| Quantification Technique | LC-ESI-MS,NA,NA |
| Labelled/Label Free | Label Free,Label Free,Label Free |
| FDR | NA,0.01,1 |
| CancerPDF_ID | CancerPDF_ID1682, CancerPDF_ID8095, CancerPDF_ID10285, |
| p-Value | NA,NA,NA |
| Software | MASCOT(v. 2.2.01),"GPM search engine, MASCOT",NA |
| Length | 17,17,17 |
| Cancer Type | Colorectal cancer,Ovarian cancer,Muscle-invasive bladder cancer |
| Database | SwissProt Database,IPI 3.71 Human Database ,SwissProt Database |
| Modification | NA,NA,NA |
| Number of Patients | 30 patients and 30 healthy controls,6 Ovarian cancer patients and 6 normal individuals,751 bladder cancer and 127 control |
| Regulation | NA,Uniquely present in case of urine of ovarian cancer patients,Differentially expressed between cancer vs normal samples |
| Validation | Leave One out Cross validation,NA,Mann-Whitney tests and areas under receiver-operator characteristic |
| Sensitivity | NA,NA,NA |
| Specificity | NA,NA,NA |
| Accuracy | NA,NA,NA |
| Peptide Atlas | NA |
| IEDB | |